RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept
Newsroom

RTI Secures Chemistry Center for Combating Antibiotic Resistance (CC4CARB) Contract from National Institute of Allergy and Infectious Diseases to Address Bottlenecks in Early Antibiotic Drug Discovery